• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强迫症:通过患者支持小组为治疗增添价值。

Obsessive-compulsive disorder: adding value to treatment through patient support groups.

作者信息

Broatch J W

机构信息

Obsessive-Compulsive Foundation, Milford, Connecticut 06460 0070, USA.

出版信息

Int Clin Psychopharmacol. 1996 Dec;11 Suppl 5:89-94.

PMID:9032005
Abstract

The development of effective medications (serotonin reuptake inhibitor antidepressants) and the widespread use of behavioural therapy (exposure and response prevention) have greatly improved the treatment options for patients with obsessive-compulsive disorder (OCD). Despite these advances, less than 20% of patients with OCD are receiving treatment. One of the main reasons for this is the lack of patient access to treatment. OCD support groups serve as a vehicle to decrease the social isolation experienced by individuals with OCD. They also serve as the doorway to treatment and the starting point on the path of recovery through educating patients about treatment and motivating them to re-enter treatment. There are currently four different types of OCD support groups. This paper gives an appraisal of each group, with emphasis on their aims, attractions and pitfalls. In addition, it provides insight into the resources available to help mental health professionals to better understand the needs of individuals with OCD.

摘要

有效药物(5-羟色胺再摄取抑制剂抗抑郁药)的研发以及行为疗法(暴露与反应阻止法)的广泛应用,极大地改善了强迫症(OCD)患者的治疗选择。尽管有这些进展,但接受治疗的强迫症患者不到20%。造成这一情况的主要原因之一是患者难以获得治疗。强迫症支持小组是减少强迫症患者所经历的社会隔离的一种手段。它们还通过向患者介绍治疗方法并激励他们重新接受治疗,成为治疗的途径和康复之路的起点。目前有四种不同类型的强迫症支持小组。本文对每个小组进行了评估,重点介绍了它们的目标、吸引力和缺陷。此外,本文还深入探讨了可帮助心理健康专业人员更好地了解强迫症患者需求的资源。

相似文献

1
Obsessive-compulsive disorder: adding value to treatment through patient support groups.强迫症:通过患者支持小组为治疗增添价值。
Int Clin Psychopharmacol. 1996 Dec;11 Suppl 5:89-94.
2
[Validation of a scale for responsibility (Salkovskis Responsibility Scale)].[责任量表(索尔科夫斯基责任量表)的验证]
Encephale. 2001 May-Jun;27(3):229-37.
3
[Therapeutic strategies for obsessive-compulsive disorder refractory to treatment].
Vertex. 2008 May-Jun;19(79):143-55.
4
Behaviour therapy for obsessive compulsive disorder in a 78-year-old woman.
Int J Geriatr Psychiatry. 1997 Apr;12(4):488-91.
5
Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.强迫症的动物模型:理解心理生物学和药理学的理论基础
Psychiatr Clin North Am. 2006 Jun;29(2):371-90. doi: 10.1016/j.psc.2006.02.007.
6
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.D-环丝氨酸不能增强强迫症的暴露反应预防疗法。
Int Clin Psychopharmacol. 2007 Jul;22(4):230-7. doi: 10.1097/YIC.0b013e32819f8480.
7
Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview.使用结构化临床访谈对伴有和不伴有共病假定强迫症谱系障碍的强迫症患者进行比较。
Compr Psychiatry. 2001 Jul-Aug;42(4):291-300. doi: 10.1053/comp.2001.24586.
8
Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment.重症强迫症患者强化住院治疗的预后预测因素
J Psychiatr Res. 2006 Sep;40(6):511-9. doi: 10.1016/j.jpsychires.2005.08.007. Epub 2005 Oct 17.
9
[Is it time for revision of the section on obsessive-compulsive disorder in the Guideline on Anxiety Disorders?].《焦虑症指南》中关于强迫症的章节是否需要修订?
Tijdschr Psychiatr. 2007;49(5):315-25.
10
Brief scheduled phone support from a clinician to enhance computer-aided self-help for obsessive-compulsive disorder: randomized controlled trial.临床医生进行简短定期电话支持以增强强迫症的计算机辅助自助:随机对照试验。
J Clin Psychol. 2005 Dec;61(12):1499-508. doi: 10.1002/jclp.20204.

引用本文的文献

1
Sport psychology and concussion: new impacts to explore.运动心理学与脑震荡:有待探索的新影响。
Br J Sports Med. 2004 Oct;38(5):519-21. doi: 10.1136/bjsm.2004.011999.